Capital Ideas
DigestGet Premium


Biotech Could Surge 245% on Manmade CBD Drug

Also inside: Relax, take the long view, and get off your phone. Plus: This gas purification company has a record backlog and a projected return of nearly 130%.

Quorum Set to Soar and Could Get Taken Out

Also inside: Led by former exec of Victoria’s Secret, this U.S. cannabis retail player could gain 60%. Plus: A gold stock that could double; And a long-time winner flashing a technical buy.

Three Grade ‘A’ Stocks from 5i Research

Also inside: This company is at an inflection point for gains of more than 120%. Plus: Newly public and flush with cash and 33% upside.

“You Make Your Money in Down Markets”: Ryan Irvine with a Cash Rich, Profitable Idea.

Also inside: A small cap company with compelling growth potential. Plus: The time is right to “jump” into these shares. And a bullish chart setup for a Chinese company.

How to Profit from Booming Gaming & eSports Sector

Also inside: Why this streamlined energy company has 38% upside.

Plus: This sweet and salty consumer staple is bubbling up to an all-time high.

Image source:

This Stock is the Next Helius: Fabrice Taylor

Also inside: This cannabis stock has tripled since our interview. It’s set to soar some more. Plus: A low-risk way to invest in the commodity cycle; And, has this uranium stock finally turned bullish?

REIT for Safety, Micro-Cap for 329% Growth

Also inside: Why it’s okay to panic just a little and protect your portfolio. Plus: A miner with superior traits and 137% upside potential.

Market Turmoil? Hang On to These Rock Solid Stocks.

Also inside: Two cannabis companies. Two different strategies. Both lots of upside.

Plus: Breakout stock a way to play cybersecurity.

Error X
Your e-mails don't match.